BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 29780631)

  • 1. Screening for early stage lung cancer and its correlation with lung nodule detection.
    Qian F; Yang W; Chen Q; Zhang X; Han B
    J Thorac Dis; 2018 Apr; 10(Suppl 7):S846-S859. PubMed ID: 29780631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Prediction Models for Identifying Malignancy in Pulmonary Nodules Detected via Low-Dose Computed Tomography.
    González Maldonado S; Delorme S; Hüsing A; Motsch E; Kauczor HU; Heussel CP; Kaaks R
    JAMA Netw Open; 2020 Feb; 3(2):e1921221. PubMed ID: 32058555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose computed tomography lung cancer screening: Clinical evidence and implementation research.
    Lancaster HL; Heuvelmans MA; Oudkerk M
    J Intern Med; 2022 Jul; 292(1):68-80. PubMed ID: 35253286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating proteome for pulmonary nodule malignancy.
    Khodayari Moez E; Warkentin MT; Brhane Y; Lam S; Field JK; Liu G; Zulueta JJ; Valencia K; Mesa-Guzman M; Nialet AP; Atkar-Khattra S; Davies MPA; Grant B; Murison K; Montuenga LM; Amos CI; Robbins HA; Johansson M; Hung RJ
    J Natl Cancer Inst; 2023 Sep; 115(9):1060-1070. PubMed ID: 37369027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vasculature surrounding a nodule: A novel lung cancer biomarker.
    Wang X; Leader JK; Wang R; Wilson D; Herman J; Yuan JM; Pu J
    Lung Cancer; 2017 Dec; 114():38-43. PubMed ID: 29173763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protocol and Rationale for the International Lung Screening Trial.
    Lim KP; Marshall H; Tammemägi M; Brims F; McWilliams A; Stone E; Manser R; Canfell K; Weber M; Connelly L; Bowman RV; Yang IA; Fogarty P; Mayo J; Yee J; Myers R; Atkar-Khattra S; Lam DCL; Rosell A; Berg CD; Fong KM; Lam S;
    Ann Am Thorac Soc; 2020 Apr; 17(4):503-512. PubMed ID: 32011914
    [No Abstract]   [Full Text] [Related]  

  • 7. Probability of cancer in pulmonary nodules detected on first screening CT.
    McWilliams A; Tammemagi MC; Mayo JR; Roberts H; Liu G; Soghrati K; Yasufuku K; Martel S; Laberge F; Gingras M; Atkar-Khattra S; Berg CD; Evans K; Finley R; Yee J; English J; Nasute P; Goffin J; Puksa S; Stewart L; Tsai S; Johnston MR; Manos D; Nicholas G; Goss GD; Seely JM; Amjadi K; Tremblay A; Burrowes P; MacEachern P; Bhatia R; Tsao MS; Lam S
    N Engl J Med; 2013 Sep; 369(10):910-9. PubMed ID: 24004118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lung cancer screening by nodule volume in Lung-RADS v1.1: negative baseline CT yields potential for increased screening interval.
    Silva M; Milanese G; Sestini S; Sabia F; Jacobs C; van Ginneken B; Prokop M; Schaefer-Prokop CM; Marchianò A; Sverzellati N; Pastorino U
    Eur Radiol; 2021 Apr; 31(4):1956-1968. PubMed ID: 32997182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The UK Lung Cancer Screening Trial: a pilot randomised controlled trial of low-dose computed tomography screening for the early detection of lung cancer.
    Field JK; Duffy SW; Baldwin DR; Brain KE; Devaraj A; Eisen T; Green BA; Holemans JA; Kavanagh T; Kerr KM; Ledson M; Lifford KJ; McRonald FE; Nair A; Page RD; Parmar MK; Rintoul RC; Screaton N; Wald NJ; Weller D; Whynes DK; Williamson PR; Yadegarfar G; Hansell DM
    Health Technol Assess; 2016 May; 20(40):1-146. PubMed ID: 27224642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multi-source data approach for personalized outcome prediction in lung cancer screening: update from the NELSON trial.
    Sidorenkov G; Stadhouders R; Jacobs C; Mohamed Hoesein FAA; Gietema HA; Nackaerts K; Saghir Z; Heuvelmans MA; Donker HC; Aerts JG; Vermeulen R; Uitterlinden A; Lenters V; van Rooij J; Schaefer-Prokop C; Groen HJM; de Jong PA; Cornelissen R; Prokop M; de Bock GH; Vliegenthart R
    Eur J Epidemiol; 2023 Apr; 38(4):445-454. PubMed ID: 36943671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ability of low-dose helical CT to distinguish between benign and malignant noncalcified lung nodules.
    Markowitz SB; Miller A; Miller J; Manowitz A; Kieding S; Sider L; Morabia A
    Chest; 2007 Apr; 131(4):1028-34. PubMed ID: 17426206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and outcomes of a comprehensive multidisciplinary incidental lung nodule and lung cancer screening program.
    LeMense GP; Waller EA; Campbell C; Bowen T
    BMC Pulm Med; 2020 Apr; 20(1):115. PubMed ID: 32349709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lung cancer screening with low-dose computed tomography: a non-invasive diagnostic protocol for baseline lung nodules.
    Veronesi G; Bellomi M; Mulshine JL; Pelosi G; Scanagatta P; Paganelli G; Maisonneuve P; Preda L; Leo F; Bertolotti R; Solli P; Spaggiari L
    Lung Cancer; 2008 Sep; 61(3):340-9. PubMed ID: 18308420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High risk lung nodule: A multidisciplinary approach to diagnosis and management.
    Mankidy BJ; Mohammad G; Trinh K; Ayyappan AP; Huang Q; Bujarski S; Jafferji MS; Ghanta R; Hanania AN; Lazarus DR
    Respir Med; 2023 Aug; 214():107277. PubMed ID: 37187432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Projected outcomes using different nodule sizes to define a positive CT lung cancer screening examination.
    Gierada DS; Pinsky P; Nath H; Chiles C; Duan F; Aberle DR
    J Natl Cancer Inst; 2014 Nov; 106(11):. PubMed ID: 25326638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of a plasma biomarker panel for discerning clinical significance of indeterminate pulmonary nodules.
    Daly S; Rinewalt D; Fhied C; Basu S; Mahon B; Liptay MJ; Hong E; Chmielewski G; Yoder MA; Shah PN; Edell ES; Maldonado F; Bungum AO; Borgia JA
    J Thorac Oncol; 2013 Jan; 8(1):31-6. PubMed ID: 23201823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening.
    Horeweg N; van Rosmalen J; Heuvelmans MA; van der Aalst CM; Vliegenthart R; Scholten ET; ten Haaf K; Nackaerts K; Lammers JW; Weenink C; Groen HJ; van Ooijen P; de Jong PA; de Bock GH; Mali W; de Koning HJ; Oudkerk M
    Lancet Oncol; 2014 Nov; 15(12):1332-41. PubMed ID: 25282285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic contrast-enhanced CT compared with positron emission tomography CT to characterise solitary pulmonary nodules: the SPUtNIk diagnostic accuracy study and economic modelling.
    Gilbert FJ; Harris S; Miles KA; Weir-McCall JR; Qureshi NR; Rintoul RC; Dizdarevic S; Pike L; Sinclair D; Shah A; Eaton R; Clegg A; Benedetto V; Hill JE; Cook A; Tzelis D; Vale L; Brindle L; Madden J; Cozens K; Little LA; Eichhorst K; Moate P; McClement C; Peebles C; Banerjee A; Han S; Poon FW; Groves AM; Kurban L; Frew AJ; Callister ME; Crosbie P; Gleeson FV; Karunasaagarar K; Kankam O; George S
    Health Technol Assess; 2022 Mar; 26(17):1-180. PubMed ID: 35289267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved discrimination between benign and malignant LDCT screening-detected lung nodules with dynamic over static
    Ye Q; Wu J; Lu Y; Naganawa M; Gallezot JD; Ma T; Liu Y; Tanoue L; Detterbeck F; Blasberg J; Chen MK; Casey M; Carson RE; Liu C
    Phys Med Biol; 2018 Sep; 63(17):175015. PubMed ID: 30095083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Difficulties encountered managing nodules detected during a computed tomography lung cancer screening program.
    Veronesi G; Bellomi M; Scanagatta P; Preda L; Rampinelli C; Guarize J; Pelosi G; Maisonneuve P; Leo F; Solli P; Masullo M; Spaggiari L
    J Thorac Cardiovasc Surg; 2008 Sep; 136(3):611-7. PubMed ID: 18805261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.